ArticleFrontiers in oncology2025

Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an

Ameya Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.